These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 15252308)
1. Immunophenotypic differences between intestinal-type and low-grade papillary sinonasal adenocarcinomas: an immunohistochemical study of 22 cases utilizing CDX2 and MUC2. Cathro HP; Mills SE Am J Surg Pathol; 2004 Aug; 28(8):1026-32. PubMed ID: 15252308 [TBL] [Abstract][Full Text] [Related]
2. Expression pattern of CK7, CK20, CDX-2, and villin in intestinal-type sinonasal adenocarcinoma. Kennedy MT; Jordan RC; Berean KW; Perez-Ordoñez B J Clin Pathol; 2004 Sep; 57(9):932-7. PubMed ID: 15333652 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2. Chu PG; Schwarz RE; Lau SK; Yen Y; Weiss LM Am J Surg Pathol; 2005 Mar; 29(3):359-67. PubMed ID: 15725805 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical distinction of intestinal-type sinonasal adenocarcinoma from metastatic adenocarcinoma of intestinal origin. Resto VA; Krane JF; Faquin WC; Lin DT Ann Otol Rhinol Laryngol; 2006 Jan; 115(1):59-64. PubMed ID: 16466101 [TBL] [Abstract][Full Text] [Related]
5. CK7, CK20, CDX2 and MUC2 Immunohistochemical staining used to distinguish metastatic colorectal carcinoma involving ovary from primary ovarian mucinous adenocarcinoma. Shin JH; Bae JH; Lee A; Jung CK; Yim HW; Park JS; Lee KY Jpn J Clin Oncol; 2010 Mar; 40(3):208-13. PubMed ID: 19926591 [TBL] [Abstract][Full Text] [Related]
6. CDX-2, cytokeratin 7 and cytokeratin 20 immunohistochemical expression in the differential diagnosis of primary adenocarcinomas of the sinonasal tract. Franchi A; Massi D; Palomba A; Biancalani M; Santucci M Virchows Arch; 2004 Jul; 445(1):63-7. PubMed ID: 15175880 [TBL] [Abstract][Full Text] [Related]
8. [CK7, CK20, SOX10 and CDX2: expressions and diagnostic values in primary adenocarcinoma of the sinonasal tract]. Yue C; Piao Y; Bai Y; Liu H; Zhang L Zhonghua Yi Xue Za Zhi; 2015 Aug; 95(30):2447-50. PubMed ID: 26711206 [TBL] [Abstract][Full Text] [Related]
9. Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2. McCluggage WG; Shah R; Connolly LE; McBride HA Int J Gynecol Pathol; 2008 Jan; 27(1):92-100. PubMed ID: 18156982 [TBL] [Abstract][Full Text] [Related]
10. Expression of CDX2, cytokeratins 7 and 20 in sinonasal intestinal-type adenocarcinoma. Ortiz-Rey JA; Alvarez C; San Miguel P; Iglesias B; Antón I Appl Immunohistochem Mol Morphol; 2005 Jun; 13(2):142-6. PubMed ID: 15894926 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical profiling of mucins in sinonasal adenocarcinomas. Taverna C; Maggiore G; Cannavicci A; Bonomo P; Santucci M; Franchi A Pathol Res Pract; 2019 Jul; 215(7):152439. PubMed ID: 31076280 [TBL] [Abstract][Full Text] [Related]
12. Signet-ring cell adenocarcinoma of sinonasal tract: an immunohistochemical study of the mucins profile. Castillo C; Buob D; Mortuaire G; Chevalier D; Aubert S; Copin MC; Leroy X Arch Pathol Lab Med; 2007 Jun; 131(6):961-4. PubMed ID: 17550327 [TBL] [Abstract][Full Text] [Related]
13. Differentiation and prognostic markers in ampullary cancer: Role of p53, MDM2, CDX2, mucins and cytokeratins. Perysinakis I; Minaidou E; Mantas D; Sotiropoulos GC; Leontara V; Tsipras H; Zografos GN; Margaris I; Kouraklis G Pathol Res Pract; 2016 Nov; 212(11):1039-1047. PubMed ID: 27688085 [TBL] [Abstract][Full Text] [Related]
14. Co-expression of CDX2 and MUC2 in gastric carcinomas: correlations with clinico-pathological parameters and prognosis. Roessler K; Mönig SP; Schneider PM; Hanisch FG; Landsberg S; Thiele J; Hölscher AH; Dienes HP; Baldus SE World J Gastroenterol; 2005 Jun; 11(21):3182-8. PubMed ID: 15929165 [TBL] [Abstract][Full Text] [Related]
15. [Sinonasal adenocarcinomas reviewed. Prognostic value of WHO 2005 histological classification]. El Ayoubi A; Poizat F; Garrel R; Costes V; Guerrier B; Essakalli L; Kzadri M; Crampette L Ann Otolaryngol Chir Cervicofac; 2009 Sep; 126(4):175-81. PubMed ID: 19591973 [TBL] [Abstract][Full Text] [Related]
17. The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-/20+ phenotype is more specific than CDX2 antibody. Bayrak R; Haltas H; Yenidunya S Diagn Pathol; 2012 Jan; 7():9. PubMed ID: 22268990 [TBL] [Abstract][Full Text] [Related]